Alkem Laboratories Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 2,207.59 | 2,502.90 | 2,530.64 |
| Operating Expense | 1,748.15 | 1,629 | 1,714.43 |
| Net Profit | 276.94 | 723.12 | 697.58 |
| Net Profit Margin | 12.54 | 28.89 | 27.57 |
| Earning Per Share | 23.17 | 60.48 | 58.34 |
| EBIDTA | 422.24 | 931.61 | 878.44 |
| Effective Tax Rate | 8.00 | 13.72 | 12.54 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 2207.59 |
| Operating Expense | 1748.15 |
| Net Profit | 276.94 |
| Net Profit Margin | 12.54 |
| Earning Per Share | 23.17 |
| EBIDTA | 422.24 |
| Effective Tax Rate | 8.00 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 8,813.44 | 7,963.85 | 9,054.55 |
| Operating Expenses Annual | 6,657.24 | 6,292.67 | 7,677.60 |
| Operating Profit Annual | 2,854.43 | 2,099.98 | 1,643.24 |
| Interest Annual | 76.11 | 80.07 | 86.40 |
| Depreciation | 261.67 | 212.50 | 204.51 |
| Net Profit Annual | 2,089.72 | 1,560.51 | 1,134.47 |
| Tax Annual | 213.82 | 33.62 | 192.52 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 8,813.44 |
| Operating Expenses Annual | 6,657.24 |
| Operating Profit Annual | 2,854.43 |
| Interest Annual | 76.11 |
| Depreciation | 261.67 |
| Net Profit Annual | 2,089.72 |
| Tax Annual | 213.82 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | -133.07 | 5.01 | 81.82 |
| Cash Flow from Operations | 2,189.41 | 1,686.56 | 1,437.42 |
| Cash Flow from Investing | -1,007.41 | -865.60 | 197.04 |
| Cash Flow from Financing | -1,036.89 | -959.04 | -1,711.27 |
| Cash Flow at the End | 12.04 | -133.07 | 5.01 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | -133.07 |
| Cash Flow from Operations | 2,189.41 |
| Cash Flow from Investing | -1,007.41 |
| Cash Flow from Financing | -1,036.89 |
| Cash Flow at the End | 12.04 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 32.32 | 26.34 | 18.15 |
| PBIT Margin (%) | 29.11 | 23.34 | 15.61 |
| PBT Margin (%) | 28.73 | 23.05 | 15.43 |
| Net PROFIT Margin (%) | 25.83 | 21.92 | 12.53 |
| Return On Networth / Equity (%) | 19.94 | 17.56 | 12.54 |
| Return On Networth /Employed (%) | 20.29 | 16.38 | 12.78 |
| Return On Assets (%) | 18.08 | 15.34 | 10.27 |
| Total Debt / Equity (X) | 0.06 | 0.11 | 0.19 |
| Asset Turnover Ratio (%) | 0.70 | 0.70 | 0.82 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 32.32 |
| PBIT Margin (%) | 29.11 |
| PBT Margin (%) | 28.73 |
| Net PROFIT Margin (%) | 25.83 |
| Return On Networth / Equity (%) | 19.94 |
| Return On Networth /Employed (%) | 20.29 |
| Return On Assets (%) | 18.08 |
| Total Debt / Equity (X) | 0.06 |
| Asset Turnover Ratio (%) | 0.70 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 1,622.02 | 1,823.09 | 1,868.74 |
| Total Current Assets Annual | 7,354 | 8,040.08 | 6,772.21 |
| Non Current Assets Annual | 7,247.53 | 5,997.72 | 5,959.01 |
| Total Shareholders Funds Annual | 12,321.83 | 10,554.61 | 9,349.85 |
| Total Assets Annual | 15,595.60 | 14,037.80 | 12,731.22 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 1,622.02 |
| Total Current Assets Annual | 7,354 |
| Non Current Assets Annual | 7,247.53 |
| Total Shareholders Funds Annual | 12,321.83 |
| Total Assets Annual | 15,595.60 |
EPS (INR)
Expected
25.58
Reported
25.57
Surprise
-0.04%
Dec 2024
EPS beaten by -0.04%
Sep 2024
EPS beaten by -0.02%
Jun 2024
EPS beaten by 0.00%
